Onconova Therapeutics, Inc.(NASDAQ : ONTX)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||4.09%||11.59||0.7%||$810.18m|
|VRTX||Vertex Pharmaceuticals, Inc.||2.58%||192.35||1.9%||$541.22m|
|GILD||Gilead Sciences, Inc.||1.17%||67.43||1.0%||$481.39m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.13%||541.08||2.7%||$394.34m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.53%||180.79||2.0%||$333.49m|
|EXAS||EXACT Sciences Corp.||-0.15%||130.78||18.1%||$175.79m|
|TXG||10X Genomics, Inc.||-2.49%||196.40||0.0%||$174.27m|
|BNGO||Bionano Genomics, Inc.||-0.55%||7.21||0.0%||$155.26m|
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.